MA
BDSI

MCF Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

MCF Advisors’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-158,440
Closed -$691K – 522
2020
Q2 		$691K Buy
+158,440
New +$712K 0.1% 56

Other funds holding BDSI

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

MCF Advisors's BDSI Position: Q3 2020 in Review

MCF Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2020, closing a stake of 158,440 shares — an estimated $691K sold.

MCF Advisors first reported a position in BDSI in Q2 2020 and held it in 1 quarter. The position peaked at $691K in Q2 2020. 147 funds tracked by Wall St. Rank hold BDSI as of Q3 2020.

  • MCF Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2020 after selling out during the quarter.
  • MCF Advisors sold 158,440 BioDelivery Sciences International, Inc. shares in Q3 2020, an estimated $691K.
  • MCF Advisors first reported a position in BioDelivery Sciences International, Inc. in Q2 2020 and held it in 1 quarter.
  • MCF Advisors's BioDelivery Sciences International, Inc. position peaked at $691K in Q2 2020.
  • 147 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2020.

Based on MCF Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.